Background The association between coffee and colorectal adenoma risk remains controversial. We conducted a metaanalysis of cohort and case-control studies to sum up the existing proof about this matter. Methods We searched Pubmed, Medline, and Embase for studies published before 1 September 2018 on coffee consumption and colorectal adenoma in any language. The different ORs were calculated for cohort and case-control studies in this study, and we use a random-effects model to aggregate the relative risks of individual studies and conduct dose response, heterogeneity, and publication bias. Results A total of 8 studies (6 case-control studies, 2 cohort studies) were identified, including 7090 subjects. In a summary analysis of all studies, high coffee intake (compared the highest with the lowest categories) was associated with a reduced risk of colorectal adenoma (odds ratio [OR] = 0.70, 95% confidence interval [CI] = 0.55-0.90). The results of subgroup analysis of adenoma location were similar with the pooled analysis, except for rectal adenoma. In the dose-response metaanalysis study, the estimated total odds ratio for increasing coffee consumption by 150 ml per day (about one cup) was 0.91 (95% CI = 0.87-0.95). Conclusions The meta-analysis demonstrates possible evidence that increased coffee intake is related to a reduced risk of colon adenoma. However, because of latent confusion and different exposure classification, this finding should be carefully considered.
Introduction
Colorectal cancer is the major account of cancer-related mortality and, globally, colorectal cancer is the third most common cancer in men and the second most common cancer in women [1] . Coffee is one of the most common drinks in the world and has been linked to the causes of colorectal cancer [2, 3] . Some epidemiological studies have discussed the relationship between coffee consumption and cancer risk [4] . The role of coffee as a dietary protective factor against cancer, including colorectal cancer, has attracted increasing attention. Several meta-analyses have been published on coffee consumption and colorectal cancer risk, and most people think that coffee can reduce the risk of colorectal cancer [5] [6] [7] [8] [9] . There are other metaanalyses that demonstrate coffee intake was not related to the risk of colorectal cancer [10] [11] [12] [13] , and subgroup analysis by case-control and cohort study has a different effect in coffee and colorectal cancer risk [14] [15] [16] . Colorectal adenomas (CRAs) are an information endpoint in the process of colon canceration. Studying CRA will make it possible for asymptomatic individuals to assess risk factors early in the formation of CRA [17, 18] . It is not clear whether coffee consumption is linked to CRAs. Whether coffee intake prevents the risk of CRA, whether the association between different coffee subtypes is consistent, and whether coffee intake has the greatest preventive effect on CRA. To study these key to questions, we conducted a meta-analysis to study the relationship between coffee intake and CRA risk, and quantify the dose-response relationship between coffee intake and the risk of CRA.
Methods and design

Search strategy
We searched Pubmed, Medline, and Embase for studies published in any language before 1 September 2018, including the relationship between coffee intake and CRA risk. Keywords and/or medical title for searching were as the following ones: (coffee or caffeine or decaffeinated or dietary intake or beverages), (colorectal or colon or rectal or rectum or bowel), and (adenomas or adenomatous or neoplasia or tumor). No restrictions were applied. Abstract screening was done in duplicate, as recommended. We also scanned the reference lists of all articles retrieved to identify other studies. If necessary, we try to contact the author for more information.
Selection of study
Studies that met the following criteria were included: (1) case-control or cohort study design; (2) data on CRA occurrence; (3) presentation of coffee consumption; (4) provision of odds ratio (OR) or relative risk (RR) and confidence interval (CI) or data needed to calculate them. Our study does not include gray literature and conference abstracts.
Extraction of data
Three reviewers (YW, JC, and XTW) extracted all data according to the selection criteria independently and crosschecked. The differences were settled through discussion. The following data from each study were extracted: the last name of the first author, year of publication, study design, study period, the country in which the study was performed, sample size, assessment of adenoma and coffee intake, follow-up, respond of survey, type of coffee and drinking classification, the OR or RR with corresponding 95% CI for each classification. If feasible, we extract risk estimates adjusted for most variables. If the same author publishes more than one article in the same population, we will choose the latest or most informative report.
Quality assessment
The Newcastle-Ottawa Scale [19] was used for quality evaluation. The scale was a nine-point scale allocation process based on the selection of the cohorts in cohort study, cases and controls in case-control study (0-4 points, respectively), the comparability of cohorts in cohort study, cases and controls in case-control study (0-2 points, respectively), and the identification of outcomes in cohort study, and exposure in case-control study (0-3 points, respectively). We allocated 0-3, 4-6, and 7-9 points for low, medium, and high-quality studies, respectively. Each study was independently scored by two researchers.
Statistical analysis
The ORs and HRs were considered to be the same as RRs in our meta-analysis [20] . We prioritized merging multivariate adjusted RR estimates such as age, sex, center, colonoscopy interval, total caloric intake, dietary fat, dietary fiber, cigarette smoking, and alcohol intake.
We calculated the summary RRs and 95% CIs for the maximum vs. minimum consumption of coffee and the dose-response analysis with a random-effects model. For studies reporting results of colon and rectal adenomas or men and women, we combined fixed-effect models to obtain an overall assessment of colon adenomas or male-female unions in primary meta-analysis [21] . Overall analyses were performed by coffee type of coffee and caffeine. We performed subgroup analyses based on adenomas subsite, study type, and the gender.
In this dose-response meta-analysis, we applied the way presented by Greenland and Longnecker [22] and Orsini et al. [23] to calculate the slopes (linear and nonlinear trends) from the correlated natural logarithm of the OR based on the coffee consumption classification. This analysis only included these studies that reported the case and control subjects number, OR, and its variance estimates for at least three quantitative exposure classifications. If coffee intake was reported as weeks or months instead of days, we computed the corresponding days. If coffee intake was not measured by cups, we used 150 ml as a cup to re-calculate the intakes to a normal scale [24] . We propose the dose-response results that increases coffee consumption by 150 milliliters per day. In 5%, 35%, 65%, and 95% distributions, a restricted cubic spline with four nodes was used. In each study, average or median coffee consumption was assigned to each corresponding OR. When coffee consumption was in a range of intakes, we set the lower boundaries of the midpoint category at 1.5 times. When the lowest classification opens, the lower bound was set to zero by us.
The Q-test and I 2 statistic was used to assess the heterogeneity. The significance level of Q-test was 0.10 [25] . The I 2 statistic represented the total variance attributable to heterogeneity. Less than 25%, 25-50%, 50-75%, and more than 75% of I 2 values demonstrated no, small, medium, and significant heterogeneity, respectively [25] . We compared these results with the fixed-effects anti-variance weights in sensitivity analyses. Egger weighted regression was used to assess the publication [26] ; the significant publication bias was P-value < 0.1. We used Stata statistical software version 12.0 to do all the statistical analysis.
Results
Search results
There were 6447 articles identified in our search, only 36 articles were considered potentially qualified after screening the titles and abstracts. By reviewing of full text articles and abstracts, 8/36 met the inclusion criteria ( Fig. 1 ). These articles were published from 1990 to 2015 and confirmed in this meta-analysis.
Study characteristics
This meta-analysis included eight studies with 7090 subjects, published between 1990 and 2015 [27] [28] [29] [30] [31] [32] [33] [34] . There were six case-control studies and two cohort studies of these studies, which were included for the analysis of the highest coffee drinking and the risk of CRA ( Table 2 ). The dose-response analysis included five studies [30] [31] [32] [33] [34] . Subgroup analysis of adenoma sites was included in four studies [27, 31, 33, 34] . The number of cases varied from 169 to 1435 in these studies, including 1757 CRAs. The average coffee drinking across classification in each study varied from 0 to 1050 ml (7 cups) per day (Table 1) . Three studies showed the relationship between coffee and decaffeinated/caffeinated coffee intake and the risk of CRA [29, 31, 34] . Three studies reported the relationship between coffee drinking and CRA risk by anatomical location [27, 33, 34] and three studies showed this risk by gender [29, 33, 34] (Table 2) .
The average score of the Newcastle-Ottawa Scale (NOS) was 7.1 (cohort study: 7.2, case and control study: 7) (Table 1) , which showed that the quality of research included in meta-analysis was high Association between coffee or caffeine intake and the CRA risk
The OR value of CRA in the highest and lowest coffee intake was 0.70, 95% CI = 0.55, 0.90 ( Fig. 2 ), whereas the OR values of CRAs in the highest and lowest caffeine consumption was 1.08, 95% CI = 0.85, 1.38 ( Fig. 3 ). All studies on coffee consumption have significant heterogeneity. For subgroup analysis by study type, the results of case-control study (OR = 0.73, 95% CI = 0.56-0.95) were similar to the analysis for the highest and lowest coffee intake other than cohort study (OR = 0.46, 95% CI = 0.13-1.65). The Egger weighted regression method showed no publication bias in the analysis of coffee or caffeine intake and CRA risk (P = 0.233, 0.607, respectively). For subgroup analysis by adenomas subsite, studies of proximal colon adenoma (OR = 0.60, 95% CI = 0.46-0.81) and distal colon adenoma (OR = 0.66, 95% CI = 0.50-0.87) showed the same results as the analysis for the highest and the lowest coffee drinking other than studies of rectal adenoma (OR = 0.86, 95% CI = 0.53-1.38) (Fig. 4) . The Egger weighted regression method showed no publication bias (P = 0.328). No heterogeneity was found for all studies (P = 0.539; I 2 = 0.0%). There was no significance in the ade adenoma(s), cas-con cases/control, CI confidence interval, NOS Newcastle-Ottawa Quality Assessment Scale,
NR not report,
OR odds ratio subgroup analysis by sex (OR = 0.90, 95% CI = 0.58-1.41), However, significant heterogeneity was found for overall and subgroup analysis (Fig. 5 ).
Dose-response meta-analysis
There were five studies included for the dose-response meta-analysis of coffee intake. We observed that there was linear and inverse relationship between coffee drinking and CRA risk. The estimated OR value for an increase coffee intake to 150 ml/day was 0.91 (95% CI = 0.87-0.95). This test did not find the problem of fitting the model due to the large p-value for goodness-of-fit (Q = 11.32, P = 0.58).
Discussion
In our meta-analysis of eight studies involving 7090 subjects, we observed that high coffee drinking was related to a reduced risk of CRA. Subgroup analyses were performed to search the cause of heterogeneity and prove the steadiness of the outcomes. There was no significant association of subgroup analysis for cohort study because the analysis included only two studies. From subgroup analysis by adenoma site, we concluded that coffee intake can reduce risk of proximal colon adenoma and distal colon adenoma but was not related to the rectal adenoma risk, which is the same as the published study that found there was not an evidence of a relationship between coffee drinking and cancer of rectum [35] , despite the unknown cause and mechanism. The content of caffeine in coffee was also decided by the type of compound used, a parameter not studied in the study [36] . In some studies, coffee species seem to have protective effects, whereas in others they are not. There was no significant relationship between CRA risk and decaffeinated/caffeinated coffee drinking in the present subgroup analyses, which was not in line with another study [35] that found drinking decaffeinated coffee may protect against colorectal cancer. However, only three studies were included in this subgroup analysis and the result should be considered with some caution. Stratifying for sex, we found there was not a significant association for male and female in this study, which was not the same as the previous research in which coffee can protect against the risk of cancer in both men and women [35] . These differences may be accidental or residual confounding factors, such as less alcohol, more fruits and vegetables, and less red meat. We also quantified the relationship between coffee intake and CRA by linear and nonlinear dose-response analyses. Linear negative correlation was observed. From a dose-response meta-analysis, the increased consumption of 150 ml of coffee per day (about a cup) was related to a statistically significant reduction in the risk of CRA by 9%. The linear correlation between coffee drinking and the risk of CRA may be authentic based on credible biological mechanisms. Coffee might be a complex mixture with various kinds of compounds.
Our research should take into account some limitations. First of all, we can not get information about major confounders from most of studies. One of them is the history of CRAs or/or cancers. Only two study [32, 33] examined the colorectal cancer among first-degree relatives. Of the six case-control studies, four studies [29, 30, 32, 33] adjusted for age, three studies [30, 32, 33] adjusted for sex and dietary fiber, three studies [28, 32, 33] adjusted for body mass index, energy, fat, and smoking. There was no adjustment in one study [27] . The two cohort studies adjusted for main latent factors, such as age, gender, smoking, and alcohol consumption. One study [34] adjusted for physical activity and two studies [31, 34] adjusted for dietary fiber and dietary fat. One study [34] adjusted for serum glucose. Thus, this result should be carefully considered because of latent confusion.
A second limitation is the possibility of different exposure classification of coffee drinking. The range between the minimum and maximum classification varies greatly among studies, which may lead to the heterogeneity in the merger analysis of all the studies. The lowest and highest levels of consumption vary among studies. Therefore, this result should be carefully considered because of different exposure classification and coffee intake ranges.
A third limitation is that some studies measured coffee drinking in milliliters, whereas others measured coffee drinking in cups. As the volume of a cup of coffee was ambiguous, it was difficult to accurately compare the intake of coffee, which may affect the results of dose-response analysis. In addition, only some studies were included for dose-response analysis. However, the fitting model has no Finally, residual confounding may persist despite multivariable adjustment of the regression models. We must take a significant heterogeneity and possible publication bias into consideration. A significant heterogeneity was shown in all studies (I 2 = 56.2%; P = 0.025) of the merger analysis. When comparing the minimum and maximum classification of coffee drinking, the heterogeneity in case-control studies (I 2 = 58.4%; P = 0.035) and cohort studies (I 2 = 71.9%; P = 0.059) were still significant. However, the Egger-weighted regression method found no publication bias in the analysis for all studies (P = 0.233). We conducted subgroup analysis on the base of some factors, such as adenomas subsite, coffee type, and the gender. None of the factors could explain the heterogeneity of subgroup analysis, except for adenoma location analysis.
Coffee drinking could reduce the risk of CRA. A lot of mechanisms might explicate the appearance. Coffee have a great deal of bioactive ingredients, including caffeine, cafestol, kahweol, and caffeoylquinic acid, which confer an anti-tumor and anti-carcinogenic effect [37] [38] [39] . Several studies have reported that caffeine can guard against DNA oxidized damage, change the apoptotic reaction, and take a turn for the cell cycle checkpoint function [40, 41] . Coffee drinking reduced the exposure of colon epithelial cells to carcinogens through enhancing the motility of colon [42] . In addition, coffee has been found to reduce the synthesis and excretion of gall acids, a potential contributor to colon cancer [43] .
Overall, the meta-analysis demonstrated the evidence that increasing coffee drinking is related to a reduced risk of colon adenoma. However, due to latent confusion and different exposure classification, this result should be carefully considered. We need to perform more researches to affirm this result and to explore which component of coffee play an important role in the prevention of colon cancer in the future.
